Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-138022
Filing Date
2016-08-19
Accepted
2016-08-19 18:52:54
Documents
2
Period of Report
2016-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3145
2 POA DOCUMENT poa.txt EX-24.4_672072 3096
  Complete submission text file 0001209191-16-138022.txt   7670
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

EIN.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12916 ANGLEWOOD CT. RALEIGH NC 27614
Business Address
Shaffer James P (Reporting) CIK: 0001488919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 161844005